AU Patent

AU2009237579C1 — Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

Assigned to Reata Pharmaceuticals Holdings LLC · Expires 2016-05-12 · 10y expired

What this patent protects

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates usef…

USPTO Abstract

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009237579C1
Jurisdiction
AU
Classification
—
Expires
2016-05-12
Drug substance claim
No
Drug product claim
No
Assignee
Reata Pharmaceuticals Holdings LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.